Molecular Engineering of membrane structure targeted photosensitizers for antitumor photodynamic therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
2. Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy10.1002/anie.202206169 ↗
3. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
4. Photodynamic therapy for hypoxic tumors: advances and perspectives10.1016/j.ccr.2021.213888 ↗
5. Photodynamic therapy in dermatology10.1016/S0190-9622(00)90209-3 ↗
6. Integration of TADF photosensitizer as “electron pump” and BSA as “electron reservoir” for boosting type I photodynamic therapy10.1021/jacs.3c01042 ↗
7. Recent advances of AIE light-up probes for photodynamic therapy10.1039/D1SC00045D ↗
8. Multi‐functional liposome: a powerful theranostic nano‐platform enhancing photodynamic therapy10.1002/advs.202100876 ↗
9. Coupling probiotics with 2D CoCuMo‐LDH nanosheets as a tumor‐microenvironment‐responsive platform for precise NIR‐II photodynamic therapy
10. A perylene diimide probe for NIR-II fluorescence imaging guided photothermal and type I/type II photodynamic synergistic therapy10.1016/j.bios.2024.116424 ↗
11. From low to No O2-dependent hypoxia photodynamic therapy (hPDT): a new perspective10.1021/acs.accounts.2c00531 ↗
12. Near-infrared-activated anticancer platinum (IV) complexes directly photooxidize biomolecules in an oxygen-independent manner10.1038/s41557-023-01242-w ↗
13. Synergistic antibacterial strategy based on photodynamic therapy: progress and perspectives10.1016/j.cej.2022.138129 ↗
14. Photoredox catalysis may be a general mechanism in photodynamic therapy
15. Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway10.1038/s41467-023-40826-5 ↗
16. Rejuvenated photodynamic therapy for bacterial infections10.1002/adhm.201900608 ↗
17. Conquering the hypoxia limitation for photodynamic therapy10.1002/adma.202103978 ↗
18. A feasible strategy of fabricating type I photosensitizer for photodynamic therapy in cancer cells and pathogens10.1021/acsnano.1c01577 ↗
19. Specific activation of photosensitizer with extrinsic enzyme for precisive photodynamic therapy10.1021/jacs.2c04017 ↗
20. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
21. Enhancement of photodynamic cancer therapy by physical and chemical factors10.1002/anie.201814098 ↗
22. A versatile fluorescent molecular probe endowed with singlet oxygen generation under white-light photosensitization10.1016/j.dyepig.2017.03.026 ↗
23. Development of sulfonamide‐functionalized charge‐reversal AIE photosensitizers for precise photodynamic therapy in the acidic tumor microenvironment
24. Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies10.1039/D0CS01370F ↗
25. Clinical development of metal complexes as photosensitizers for photodynamic therapy of cancer10.1002/anie.202112236 ↗
26. Heteroatom-containing organic molecule for two-photon fluorescence lifetime imaging and photodynamic therapy10.1021/acs.jpcc.8b05460 ↗
27. Photodynamic therapy based on organic small molecular fluorescent dyes10.1016/j.cclet.2019.04.017 ↗
28. Organic sonosensitizers for sonodynamic therapy: from small molecules and nanoparticles toward clinical development
29. Ultra‐small nano‐assemblies as tumor‐targeted and renal clearable theranostic agent for photodynamic therapy
30. Hypotoxic and rapidly metabolic PEG-PCL-C3-ICG nanoparticles for fluorescence-guided photothermal/photodynamic therapy against OSCC10.1021/acsami.7b09522 ↗
31. Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer10.1021/acs.accounts.0c00606 ↗
32. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
33. Inorganic nanomaterials with intrinsic singlet oxygen generation for photodynamic therapy10.1002/advs.202102587 ↗
34. Dimensional reduction enhances photodynamic therapy of metal–organic nanophotosensitizers10.1021/jacs.2c00384 ↗
35. Molecular engineering to boost AIE‐active free radical photogenerators and enable high‐performance photodynamic therapy under hypoxia10.1002/adfm.202002057 ↗
36. Stimuli‐responsive reversible switching of intersystem crossing in pure organic material for smart photodynamic therapy10.1002/anie.201905129 ↗
37. Synthesis and application of novel tricyanofuran hydrazone dyes as sensors for detection of microbes10.1111/cote.12233 ↗
38. Universal quenching of common fluorescent probes by water and alcohols10.1039/D0SC05431C ↗